<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-119
Date of Submission: 2025-02-26

This report was submitted by a Patient from Bradshaw PLC Medical Center concerning patient ANON-PX-8386. The subject is a 61-year-old female with a significant medical history including anxiety, type 2 diabetes, seasonal allergies, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin administered via the Subcutaneous route at a dosage of 420mg, initiated on 2025-02-02 for Bacterial infection and discontinued on 2025-02-16.

On approximately 2025-02-08, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Stevens-Johnson syndrome, Vomiting. The Anaphylaxis was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed also and advised laugh. The current patient status regarding this symptom is 'Not Recovered'. The Stevens-Johnson syndrome was classified as Severe in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. The Vomiting was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 7 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Fact occur heavy research number. Avoid good painting who house. Age ball space.</data>
report_id: ADR-2025-119
report_date: '2025-02-26'
patient_details:
  patient_id: ANON-PX-8386
  gender: Female
  relevant_history:
  - anxiety
  - type 2 diabetes
  - seasonal allergies
  - chronic kidney disease
  age_at_reaction: 61
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 420mg
  route_of_administration: Subcutaneous
  start_date: '2025-02-02'
  indication_for_use: Bacterial infection
  end_date: '2025-02-16'
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2025-02-08'
  severity: Severe
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed also and advised laugh.
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-02-08'
  severity: Severe
  outcome: Not Recovered
  intervention_required: true
- symptom_name: Vomiting
  onset_date: '2025-02-08'
  severity: Moderate
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 7
reporting_facility: Bradshaw PLC Medical Center
reporter_type: Patient
notes: Fact occur heavy research number. Avoid good painting who house. Age ball space.
